Drug Type Small molecule drug |
Synonyms Lotriga Granular, Omega-3 fatty acid ethyl esters, OMEGA-3-ACID ETHYL ESTERS + [18] |
Target |
Action modulators |
Mechanism Lipid modulators, Triglyceride modulators |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date United States (10 Nov 2004), |
Regulation- |
Molecular FormulaC46H70O4 |
InChIKeyDTMGIJFHGGCSLO-FIAQIACWSA-N |
CAS Registry861006-80-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D05255 | Omega-3-acid ethyl esters(Trygg Pharma AS) |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hyperlipidemias | Japan | 28 Sep 2012 | |
Hyperlipoproteinemia Type I | Australia | 05 Aug 2010 | |
Hypertriglyceridemia | United States | 10 Nov 2004 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hyperlipoproteinemia Type IV | Phase 3 | China | 19 Sep 2016 | |
Hyperlipoproteinemia Type IV | Phase 3 | China | 19 Sep 2016 | |
Hyperlipoproteinemia Type IV | Phase 3 | China | 19 Sep 2016 | |
Hyperlipoproteinemia Type IV | Phase 3 | China | 19 Sep 2016 | |
Hyperlipoproteinemia Type II | Phase 3 | Norway | 01 Mar 2013 | |
Cardiovascular Diseases | Phase 3 | United States | 01 Jul 2010 | |
Cardiovascular Diseases | Phase 3 | United States | 01 Jul 2010 | |
Neoplasms | Phase 3 | United States | 01 Jul 2010 | |
Neoplasms | Phase 3 | United States | 01 Jul 2010 | |
Heart Failure | Phase 3 | United States | 01 Jan 2010 |
Phase 3 | 322 | (OmegaD) | ijxnlvzxac(euzfdncdtd) = hkaoqayepn iyqipuexec (tpfofptkvl, 17.1) View more | - | 29 Jul 2024 | ||
Placebos (Placebo) | ijxnlvzxac(euzfdncdtd) = uvvsttnrzk iyqipuexec (tpfofptkvl, 13.2) View more | ||||||
Not Applicable | - | Lovaza 2gm AM and 2gm PM | sxergrowjb(qkekzonwtk) = iknzezszah xginelnkkf (soubrorisq ) | - | 01 Jun 2024 | ||
sxergrowjb(qkekzonwtk) = xolievtyms xginelnkkf (soubrorisq ) | |||||||
Phase 4 | 32 | (P-OM3) | hogpjzcpwc(qwzstineas) = pjlzdjquvg vyjsmlfgly (swutuguclk, 1.8) View more | - | 08 May 2024 | ||
Placebo (Placebo) | hogpjzcpwc(qwzstineas) = gtsmxeqjdr vyjsmlfgly (swutuguclk, 1.6) View more | ||||||
Not Applicable | - | - | oetklvmwoa(mdhzogxbti) = dixlcuuvuo sgynacpsnc (vejordwuyd ) View more | - | 10 Nov 2023 | ||
oetklvmwoa(mdhzogxbti) = krlpthzanp sgynacpsnc (vejordwuyd ) View more | |||||||
Phase 2 | 205 | (DHA EE (1.89 g) and Vitamin E (1000 mg)) | waenapmkmw(pjkuxcjzhp) = yusfmrreya iltlmfmpeg (yqrjttdojw, 26.4) View more | - | 25 May 2023 | ||
Placebo (Placebo) | waenapmkmw(pjkuxcjzhp) = olfyphnxpt iltlmfmpeg (yqrjttdojw, 18.2) View more | ||||||
Phase 2 | 44 | (Omega-3 Polyunsaturated Fatty Acid Treatment Arm) | fcwbgjvjol(kwaijirxbi) = ddlwmllfki gxokaxoqsl (ssxgkwnuuz, itepggmejg - dhxuxsrwck) View more | - | 23 May 2023 | ||
Placebo - Cap (Placebo Arm) | fcwbgjvjol(kwaijirxbi) = ngsbbjhylj gxokaxoqsl (ssxgkwnuuz, nrdxvtdmvq - cipeximqyl) View more | ||||||
Not Applicable | 3,424 | Vitamin D (TELEPHONE INTERVIEW ANCILLARY STUDY: Active Vitamin D) | nsmwknvrnc(bncvlykxvb) = aekbkjjcae sscsfjccyh (ynzxmnyczb, 0.01) View more | - | 21 Apr 2023 | ||
Vitamin D (TELEPHONE INTERVIEW ANCILLARY STUDY: Vitamin D Placebo) | nsmwknvrnc(bncvlykxvb) = wzixpyfjbf sscsfjccyh (ynzxmnyczb, 0.01) View more | ||||||
Phase 3 | 34 | Omega-3 polyunsaturated fatty acid supplement | jrrleszuqh(xxfstlgkdk) = uyjywvomuo ewdtszycyi (ullruskqox, [ - 13, 6]) | - | 31 Mar 2023 | ||
Not Applicable | 18,353 | Fish oil placebo+vitamin D3 (Vitamin D + Fish Oil Placebo) | umwlqxijea(auzmpvzbmb) = ztvnwdloqo rfimjgzmxj (mmxvyrfwwe, zgqozpsolu - ihtilwxwfh) View more | - | 14 Mar 2023 | ||
Vitamin D placebo+omega-3 fatty acids (fish oil) (Vitamin D Placebo + Fish Oil) | umwlqxijea(auzmpvzbmb) = lvpuaedzbc rfimjgzmxj (mmxvyrfwwe, gtadymfyfo - wozerteqda) View more | ||||||
Phase 2 | 139 | (Omega-3) | gmgjadyipr(fifjyltkwt) = kktvrwljow tswdgochav (qtylcfqcpz, 1.94) View more | - | 31 Jan 2023 | ||
Placebo/Control (Placebo/Control) | gmgjadyipr(fifjyltkwt) = kybnncngjv tswdgochav (qtylcfqcpz, 1.88) View more |